VRNA stock run up is way overdone. Leave it to scumbag analysts to upgrade a stock only after a major run up where are these douchebags when the stocks are cheap? Pump n dump much? Purchased a total of 70 puts so far will add for each $1 share price increase until correction
VRNA overbought on positive lung cancer results. These money losing pharma stocks always tend to overshoot. We should correct under $15 in coming days. Purchased 50 Feb 17th $20 puts. Will add for each $1 increase in share price.
VRNA has some decent moves today during the first half of the day. The stock since the peak of the $14 zone has pulled back to the $9-$10 zone. Recently the stock was given an upgrade on Zacks for a strong buy which is always a good sentiment indicator from a business perspective. Could see another 10-20% move tomorrow? (Not financial advice) Recent...
Hi all, 1pm update for stock market vrna strong uptrend forming nicely , if brk above resistance red line a bo can follow . NOT trading advise either. #1. Atm=the ideas for SHORT-term . #2. Over upper resistance line=bullish, &under =bearish. #3. Chart tutorial. All in1 trendline to hit target upper resistance or support level lines n that's it...+MUST...
I found this pattern at tickeron website with the following data: STATUS = Confirmed CURRENT CONFIDENCE = 84% TARGET (EXIT) PRICE = 3.84 USD BREAKOUT (ENTRY) PRICE = 6.60 USD DISTANCE TO TARGET PRICE = 39.95% EMERGED ON = Aug 19, 12:00 PM (EDT) CONFIRMED ON = Sep 03, 01:03 PM (EDT) WITH CONFIDENCE LEVEL = 98% The Three Falling Peaks pattern forms when three minor...
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription Funding to support Phase 3 ENHANCE clinical program in COPD The Financing comprises a private placement of 39,090,009 of the Company’s American Depositary Shares (“ADSs”), each representing eight ordinary shares of the Company (“Ordinary Shares”), at a price of $4.50 per ADS,...
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. hoping for bullish!
VRNA reached the trend resistance line and has acted tough in the past. Such volatility on stock chart is gaining market attention. The company presently has an “outperform” rating on the stock. I can feel this stock has a potential upside of 101.1% from its current price of $5.36.
Hi Guys, Some fantastic moves on the Small Cap side of things. The Pharma stocks are on fire! TrendSpotter was in the thick of it catching some moves. Enjoy, Enda